|
169 |
I thought the Cc was pretty informative overall. |
g2 |
11/15/2012 11:36:56 AM |
|
167 |
On the call, Jerry noted that the IMS data does |
tangerine |
11/15/2012 11:27:54 AM |
|
166 |
Phendimetrazine revenue IMS #s don't include the |
NASDAQ2020 |
11/15/2012 11:24:13 AM |
|
165 |
yes. Naltrexone is the next one to be approved |
tangerine |
11/15/2012 11:23:30 AM |
|
164 |
Watson can afford to wait it out right now. I |
tangerine |
11/15/2012 11:23:01 AM |
|
163 |
Did I hear that right, Elite is awaiting the |
AJM16w |
11/15/2012 11:22:36 AM |
|
162 |
I agree, but they are essentially in an arms race |
steges |
11/15/2012 11:14:02 AM |
|
161 |
Like Jerry said in an earlier CC, the value of |
tangerine |
11/15/2012 11:11:20 AM |
|
160 |
Yes, things looking good. Gonna take awhile but |
steges |
11/15/2012 11:09:52 AM |
|
159 |
Depends f what your plan is plus you don't know |
tangerine |
11/15/2012 11:08:26 AM |
|
157 |
API issue sounds like it is about to be resolved |
tangerine |
11/15/2012 11:06:17 AM |
|
156 |
Novel should cover it all. That would be |
steges |
11/15/2012 11:03:01 AM |
|
155 |
They like the Socius deal because they can draw |
tangerine |
11/15/2012 11:01:51 AM |
|
154 |
Good call. Socius deal available, same economics |
tangerine |
11/15/2012 11:00:36 AM |
|
153 |
Hard to tell. They need to really move it on the |
steges |
11/15/2012 10:59:54 AM |
|
152 |
Are BE studies on track any before en of |
NASDAQ2020 |
11/15/2012 10:42:53 AM |
|
150 |
Im on hold 10 mins?? has it |
NASDAQ2020 |
11/15/2012 10:01:19 AM |
|
149 |
One would think Naltrexone will be right around |
ryan g |
11/15/2012 9:50:32 AM |
|
148 |
Interesting, nice publicity |
g2 |
11/15/2012 9:24:04 AM |
|
147 |
Something else to think about regarding |
tangerine |
11/15/2012 8:38:37 AM |
|
146 |
Of course it is.... 30 million dollar |
tangerine |
11/15/2012 7:40:58 AM |
|
145 |
That helps. Interestingly this was listed as |
Hike |
11/15/2012 7:34:12 AM |
|
144 |
Phendametrazine launched!!! - Cheer up grump |
tangerine |
11/15/2012 7:32:26 AM |
|
143 |
I agree man. Hopefully they spout off something |
mrwrn2010 |
11/15/2012 3:46:49 AM |
|
142 |
Discontinued Development Isradipine |
Couch |
11/14/2012 10:02:06 PM |
|
141 |
If you go through the mikah agreements you will |
tangerine |
11/14/2012 9:58:19 PM |
|
140 |
Isradapine issue is very concerning... See where |
steges |
11/14/2012 9:46:51 PM |
|
139 |
The report seems to be about what was expected. |
Couch |
11/14/2012 9:20:45 PM |
|
138 |
Also, we should see the sale of their R&D debt |
tangerine |
11/14/2012 6:01:08 PM |
|
137 |
Good news is that Elite keeps increasing $$$ |
tommyschenck |
11/14/2012 5:49:39 PM |
|
136 |
Honestly I am very concerned about the filing |
soccadoc |
11/14/2012 5:42:15 PM |
|
135 |
Not really. I was hoping to get closer to 700k |
tangerine |
11/14/2012 5:29:43 PM |
|
134 |
That has been in their filings since at least |
Hike |
11/14/2012 5:27:54 PM |
|
132 |
Verydisappointing. Very. This company is really |
Hike |
11/14/2012 5:14:05 PM |
|
131 |
This is a surprise to me - anyone else? |
tommyschenck |
11/14/2012 5:02:14 PM |
|
129 |
Elite Pharmaceuticals, Inc. Reports Financial |
tommyschenck |
11/14/2012 4:48:14 PM |
|
128 |
I recall someone asked during one of the recent |
Couch |
11/14/2012 3:02:51 PM |
|
126 |
That is interesting. The FTC is focused on the |
tangerine |
11/14/2012 12:45:41 PM |
|
125 |
I see this as GREAT news for Elite. A strike |
tommyschenck |
11/14/2012 12:22:33 PM |
|
124 |
I bwas thinking the same thing, should be |
g2 |
11/14/2012 12:17:14 PM |
|
123 |
I think is how it was last time. Should come out |
tangerine |
11/14/2012 11:47:02 AM |
|
122 |
It IS interesting to me that the 10Q hasn't been |
tommyschenck |
11/14/2012 11:34:14 AM |
|
121 |
Welcome all the new mods, full |
g2 |
11/14/2012 9:56:23 AM |
